Gene G. Kinney, CSO & Head of R&D at Prothena Corp plc (PRTA), sold 30,000 shares at $65.46 ($2.0M) on 2015-12-09, disclosed to the SEC on 2015-12-11.
Scheduled sale ($2.0M) by CSO & Head of R&D under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $65.46 | 8,201 | $537K | 27.1% |
| 2 | $66.37 | 20,439 | $1.4M | 68.4% |
| 3 | $67.05 | 1,360 | $91K | 4.6% |
| Total | $66.15 avg | 30,000 | $2.0M | 100% |
| Filing → |
| PRTA | SELL | 2022-09-23 | $174K | — | Filing → |
| PRTA | SELL | 2022-08-19 | $140K | — | Filing → |
| PRTA | SELL | 2022-08-12 | $2.2M | — | Filing → |